Silverarc Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-179,085	Closed	-$15M	–	85
2024 Q4	$15M	Buy	179,085 +11,975	+7%	+$984K	3.34%	12
2024 Q3	$12.2M	Sell	167,110 -25,235	-13%	-$1.9M	2.76%	10
2024 Q2	$13.2M	Buy	192,345 +157,538	+453%	+$10.9M	3.25%	10
2024 Q1	$2.41M	Sell	34,807 -45,193	-56%	-$3.11M	0.68%	44
2023 Q4	$5.73M	Sell	80,000 -128,730	-62%	-$7.41M	1.77%	21
2023 Q3	$10.9M	Buy	208,730 +10,007	+5%	+$583K	4.05%	6
2023 Q2	$12.6M	Buy	198,723 +73,688	+59%	+$4.59M	4.25%	6
2023 Q1	$6.77M	Sell	125,035 -15,331	-11%	-$741K	3.04%	10
2022 Q4	$7.43M	Buy	140,366 +4,240	+3%	+$212K	2.56%	16
2022 Q3	$6.33M	Sell	136,126 -177,836	-57%	-$9.29M	2.69%	18
2022 Q2	$17.9M	Buy	313,962 +5,143	+2%	+$292K	8.4%	2
2022 Q1	$18.9K	Buy	308,819 +113,819	+58%	+$5.91M	8.95%	3
2021 Q4	$10.2M	Buy	195,000 +93,110	+91%	+$3.91M	4.57%	4
2021 Q3	$3.8M	Sell	101,890 -11,368	-10%	-$395K	2.2%	14
2021 Q2	$4.62K	Sell	113,258 -16,859	-13%	-$623K	2.26%	15
2021 Q1	$4.42M	Sell	130,117 -69,883	-35%	-$2.42M	2.47%	11
2020 Q4	$6.36M	Buy	+200,000	New	+$5.26M	3.88%	3